Brief: Innovative Pharmaceutical Biotech terminates subscription agreements

Starcoin

14/04/2016 24:42

April 14 (Reuters) - Innovative Pharmaceutical Biotech Ltd  0399.HK : 
 
 * Informed by subscriber A and subscriber C that they'll not be able to perform 
their payment obligation under respective subscription agreement 
 * Termination of subscription agreements with Guoxin Global and Shanghai 
Rongding equity investment management 
 * Refers to announcement made by co in relation to issue of convertible bonds 
to subscribers under general mandate 
 * Termination of subscription agreements will not have any material adverse 
effect on financial position of the group 
 * Source text for Eikon  ID:nASX3t8Df7  
 
 ((For more news, please click here  0399.HK ))  
 ((Bengaluru Newsroom; +91 80 6749 1130))